TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
71.76
-2.53 (-3.41%)
Jul 22, 2026, 12:18 PM EDT - Market open
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.48 billion as of July 22, 2026. Its market cap has decreased by -29.25% in one year.
Market Cap
2.48B
Enterprise Value
2.90B
1-Year Change
-29.25%
Ranking
Category
Stock Price
$71.76
ChartMarket Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.48B, an increase of 448.11%. That is a compound annual growth rate of 26.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 2.48B | -40.34% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iRhythm Holdings | 3.58B |
| Haemonetics | 3.55B |
| Integer Holdings | 3.27B |
| Establishment Labs Holdings | 2.82B |
| Neogen | 2.16B |
| Axogen | 2.14B |
| UFP Technologies | 1.89B |
| NovoCure | 1.85B |